Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accord, Aquestive, Aribio, Astrazeneca, Bavarian Nordic, Dermavant, Ena, Immix, Mannkind, Nkgen, Octapharma, Prime, Sellas, Soleno, Vertex, X4.